PACB
NASDAQStockPacific Biosciences of California, Inc.
$1.26-0.09 (-6.30%)
52-Week Range
$0.91
$2.67
Key Stats
Market Cap
380.5M
P/E Ratio
N/A
Dividend Yield
N/A
Beta
2.30
Volume
5.3M
Avg Volume
6.0M
Performance
1M
-29.83%
3M
-40.09%
6M
+5.83%
YTD
-30.98%
1Y
-0.78%
3Y
-85.45%
5Y
-96.40%
Price Chart
ETF Exposure
PACB is held by 54 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| LOPX | Direxion Low Priced Stock ETF | 2.36% |
| ARKG | ARK Genomic Revolution ETF | 1.31% |
| NIFE | Direxion Fallen Knives ETF | 1.28% |
| ARKK | ARK Innovation ETF | 0.44% |
| EDOC | Global X Telemedicine & Digital Health ETF | 0.42% |
| IDNA | iShares Genomics Immunology and Healthcare ETF | 0.38% |
| GNOM | Global X - Genomics & Biotechnology ETF | 0.37% |
| QQQS | Invesco NASDAQ Future Gen 200 ETF | 0.28% |
| WDNA | WisdomTree BioRevolution Fund | 0.25% |
| STSB | iShares Factors US Small Blend Style ETF | 0.11% |
| JHMH | John Hancock Multifactor Health Care ETF | 0.09% |
| MEDX | Horizon Kinetics Medical ETF | 0.08% |
| PRFZ | Invesco RAFI US 1500 Small-Mid ETF | 0.07% |
| GINN | Goldman Sachs Innovate Equity ETF | 0.05% |
| HEAL.L | iShares Healthcare Innovation UCITS ETF | 0.05% |
| VTWV | Vanguard Russell 2000 Value ETF | 0.04% |
| IBB | iShares Biotechnology ETF | 0.03% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 0.03% |
| IWN | iShares Russell 2000 Value ETF | 0.03% |
| VFMO | Vanguard U.S. Momentum Factor ETF | 0.02% |
| BIB | ProShares - Ultra Nasdaq Biotechnology | 0.02% |
| VTWO | Vanguard Russell 2000 ETF | 0.02% |
| RESM | Columbia Research Enhanced Small Cap ETF | 0.02% |
| RSSL | Global X - Russell 2000 ETF | 0.01% |
| IWM | iShares Russell 2000 ETF | 0.01% |
| ISCV | iShares Morningstar Small-Cap Value ETF | 0.01% |
| JKL | iShares Morningstar Small-Cap Value ETF | 0.01% |
| SCHA | Schwab U.S. Small-Cap ETF | 0.01% |
| AVSC | Avantis U.S. Small Cap Equity ETF | 0.01% |
| TECB | iShares U.S. Tech Breakthrough Multisector ETF | 0.01% |
| UWM | ProShares - Ultra Russell2000 | 0.01% |
| VHT | Vanguard Health Care ETF | 0.01% |
| VXF | Vanguard Extended Market ETF | 0.01% |
| URTY | ProShares - UltraPro Russell2000 | 0.01% |
| ISCB | iShares Morningstar Small-Cap ETF | 0.01% |
| JKJ | iShares Morningstar Small-Cap ETF | 0.01% |
| SMMD | iShares Russell 2500 ETF | 0.00% |
| HDG | ProShares - Hedge Replication ETF | 0.00% |
| ITOT | iShares Core S&P Total U.S. Stock Market ETF | 0.00% |
| IWV | iShares Russell 3000 ETF | 0.00% |
| SCHB | Schwab U.S. Broad Market ETF | 0.00% |
| VTHR | Vanguard Russell 3000 ETF | 0.00% |
| VTI | Vanguard Total Stock Market ETF | 0.00% |
| AVUS | Avantis U.S. Equity ETF | 0.00% |
| DFAC | Dimensional - US Core Equity 2 ETF | 0.00% |
| ITDB | iShares LifePath Target Date 2030 ETF | 0.00% |
| ITDC | iShares LifePath Target Date 2035 ETF | 0.00% |
| ITDD | iShares LifePath Target Date 2040 ETF | 0.00% |
| ITDE | iShares LifePath Target Date 2045 ETF | 0.00% |
| ITDF | iShares LifePath Target Date 2050 ETF | 0.00% |
Page 1 of 2Next
About PACB ETF Exposure
Pacific Biosciences of California, Inc. (PACB) is held by 54 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 380.5M, PACB is a widely held institutional stock. The stock currently trades at $1.26. Investors can gain exposure to PACB through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold PACB, sorted by portfolio weight.